Sabra Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Sabra Healthcare REIT
SBRA Stock  USD 18.52  0.11  0.60%   
Sabra Healthcare financial statements provide useful quarterly and yearly information to potential Sabra Healthcare REIT investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sabra Healthcare financial statements helps investors assess Sabra Healthcare's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sabra Healthcare's valuation are summarized below:
Gross Profit
372.8 M
Profit Margin
0.1422
Market Capitalization
4.4 B
Enterprise Value Revenue
9.9243
Revenue
683.2 M
We have found one hundred twenty available fundamental trend indicators for Sabra Healthcare REIT, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Sabra Healthcare REIT current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 3.5 B, whereas Enterprise Value is forecasted to decline to about 3.2 B.

Sabra Healthcare Total Revenue

404.91 Million

Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 116.9 M, Interest Expense of 83.2 M or Selling General Administrative of 29.5 M, as well as many indicators such as Price To Sales Ratio of 10.02, Dividend Yield of 0.0653 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
  
Check out the analysis of Sabra Healthcare Correlation against competitors.

Sabra Healthcare Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.2 B5.4 B3.8 B
Slightly volatile
Short and Long Term Debt Total2.2 B2.4 B2 B
Slightly volatile
Total Current Liabilities1.9 B1.8 B308.4 M
Slightly volatile
Total Stockholder Equity2.1 B2.8 B1.9 B
Slightly volatile
Other Liabilities47.8 M40.4 M50.8 M
Pretty Stable
Property Plant And Equipment Net3.3 B4.6 B1.6 B
Slightly volatile
Net Debt1.9 B2.4 B1.7 B
Slightly volatile
Accounts Payable76.6 M73.8 M70.1 M
Slightly volatile
Cash39.2 M41.3 M76.1 M
Very volatile
Non Current Assets Total29.4 M30.9 M2.9 B
Slightly volatile
Other Assets5.4 B5.1 B1.5 B
Slightly volatile
Long Term Debt2.4 B2.3 B944.7 M
Slightly volatile
Cash And Short Term Investments87 M46.7 M79.7 M
Very volatile
Common Stock Total Equity2.8 M2.7 M1.4 M
Slightly volatile
Common Stock Shares Outstanding131.1 M232.8 M120 M
Slightly volatile
Short Term Investments18 M18.9 M68.8 M
Slightly volatile
Liabilities And Stockholders Equity4.2 B5.4 B3.8 B
Slightly volatile
Non Current Liabilities Total775 M815.8 M1.6 B
Slightly volatile
Other Stockholder Equity2.9 B4.5 B2.6 B
Slightly volatile
Total Liabilities2 B2.6 B1.9 B
Slightly volatile
Property Plant And Equipment Gross627.4 M757.1 M651.2 M
Slightly volatile
Total Current Assets387.9 M212.7 M355 M
Slightly volatile
Common Stock1.4 M2.3 M1.3 M
Slightly volatile
Intangible Assets59.5 M30.9 M51.1 M
Slightly volatile
Net Tangible Assets2.4 B3.5 B2 B
Slightly volatile
Net Receivables98.1 M103.3 M189.4 M
Slightly volatile
Long Term Debt Total2.8 B2.7 B1 B
Slightly volatile
Capital Surpluse2.9 B5.2 B2.5 B
Slightly volatile
Short Term Debt186.8 M196.6 M685.6 M
Slightly volatile
Long Term Investments166.6 M194.7 M116.5 M
Slightly volatile
Short and Long Term Debt89.7 M94.4 M840.8 M
Slightly volatile
Capital Lease Obligations49.6 M32.5 M78 M
Slightly volatile
Net Invested Capital4.7 B5.2 B6.3 B
Slightly volatile
Non Current Liabilities Other49.6 M32.5 M78 M
Slightly volatile
Net Working Capital251.6 M311.9 M499.4 M
Slightly volatile
Capital Stock2.4 M2.3 M2 M
Slightly volatile

Sabra Healthcare Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization116.9 M183.1 M107 M
Slightly volatile
Selling General Administrative29.5 M47.5 M27 M
Slightly volatile
Total Revenue404.9 M655.8 M370.6 M
Slightly volatile
Gross Profit326.2 M277.5 M298.5 M
Slightly volatile
Other Operating Expenses216.3 M420.8 M197.9 M
Slightly volatile
Operating Income163 M218.6 M149.2 M
Slightly volatile
EBITDA280.2 M418.2 M256.5 M
Slightly volatile
Total Operating Expenses40.3 M42.4 M119.7 M
Slightly volatile
Cost Of Revenue397.2 M378.3 M101.2 M
Slightly volatile
Net Income From Continuing Ops13.1 M13.8 M82.7 M
Very volatile
Preferred Stock And Other Adjustments10.8 M11.2 M9.6 M
Slightly volatile
Tax Provision1.8 M2 M1.3 M
Slightly volatile
Reconciled Depreciation191.7 M183.1 M146.8 M
Slightly volatile
Interest Income6.7 M7.8 M6 M
Slightly volatile

Sabra Healthcare Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation8 M7.9 M7.3 M
Slightly volatile
Depreciation116.9 M183.1 M107 M
Slightly volatile
Total Cash From Operating Activities215.7 M300.6 M197.4 M
Slightly volatile
End Period Cash Flow89.7 M46.7 M82.1 M
Pretty Stable
Begin Period Cash Flow98.5 M53.9 M89.1 M
Pretty Stable
Dividends Paid202.1 M277.4 M174.8 M
Slightly volatile
Other Cashflows From Investing Activities110.2 M105.7 M96.5 M
Slightly volatile
Issuance Of Capital Stock247 M277.8 M302.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio10.025.03069.1751
Slightly volatile
Dividend Yield0.06530.08410.0808
Pretty Stable
PTB Ratio1.531.17721.3969
Slightly volatile
Days Sales Outstanding54.6157.4832187
Pretty Stable
Book Value Per Share12.4612.121515.3611
Pretty Stable
Operating Cash Flow Per Share1.31.31.5996
Pretty Stable
Stock Based Compensation To Revenue0.01150.01210.0311
Slightly volatile
Capex To Depreciation0.210.222.3731
Slightly volatile
PB Ratio1.531.17721.3969
Slightly volatile
EV To Sales8.268.698115.5621
Slightly volatile
Inventory Turnover0.430.451.5072
Slightly volatile
Days Of Inventory On Hand873831342
Slightly volatile
Payables Turnover5.385.12691.162
Slightly volatile
Sales General And Administrative To Revenue0.110.07240.1009
Slightly volatile
Average Inventory64.6 M86.3 M70.9 M
Slightly volatile
Capex To Revenue0.06450.06790.7034
Slightly volatile
Cash Per Share0.250.26041.0559
Pretty Stable
POCF Ratio17.0310.976715.5799
Slightly volatile
Interest Coverage2.151.93531.9246
Very volatile
Capex To Operating Cash Flow0.10.111.6948
Slightly volatile
Days Payables Outstanding67.6371.19261.8 K
Slightly volatile
EV To Operating Cash Flow30.5618.979327.9661
Slightly volatile
Intangibles To Total Assets0.00550.00570.0122
Pretty Stable
Net Debt To EBITDA5.465.752311.1403
Slightly volatile
Current Ratio0.110.12034.6915
Slightly volatile
Tangible Book Value Per Share12.2211.987915.064
Pretty Stable
Receivables Turnover6.676.34973.9017
Pretty Stable
Graham Number3.834.028314.9044
Pretty Stable
Shareholders Equity Per Share12.4512.121515.356
Pretty Stable
Debt To Equity1.280.86141.1677
Slightly volatile
Capex Per Share0.170.182.3179
Slightly volatile
Revenue Per Share2.472.83673.0465
Pretty Stable
Interest Debt Per Share19.2110.930117.5808
Pretty Stable
Debt To Assets0.550.44820.5077
Slightly volatile
Enterprise Value Over EBITDA12.9613.642425.8686
Slightly volatile
Short Term Coverage Ratios1.451.528643.863
Slightly volatile
Operating Cycle54.6157.4832380
Pretty Stable
Price Book Value Ratio1.531.17721.3969
Slightly volatile
Days Of Payables Outstanding67.6371.19261.8 K
Slightly volatile
Price To Operating Cash Flows Ratio17.0310.976715.5799
Slightly volatile
Operating Profit Margin0.470.33330.4346
Pretty Stable
Company Equity Multiplier2.451.92192.2449
Slightly volatile
Long Term Debt To Capitalization0.570.44170.521
Slightly volatile
Total Debt To Capitalization0.570.46280.524
Slightly volatile
Return On Capital Employed0.05080.06040.0465
Pretty Stable
Debt Equity Ratio1.280.86141.1677
Slightly volatile
Ebit Per Revenue0.470.33330.4346
Pretty Stable
Quick Ratio0.110.12034.3738
Slightly volatile
Dividend Paid And Capex Coverage Ratio0.781.08330.9054
Slightly volatile
Net Income Per E B T0.830.8733.3709
Slightly volatile
Cash Ratio0.02220.02340.9366
Pretty Stable
Operating Cash Flow Sales Ratio0.590.45830.5451
Pretty Stable
Days Of Inventory Outstanding873831342
Slightly volatile
Days Of Sales Outstanding54.6157.4832187
Pretty Stable
Cash Flow Coverage Ratios0.0880.12450.1043
Slightly volatile
Price To Book Ratio1.531.17721.3969
Slightly volatile
Fixed Asset Turnover0.110.1264.845
Pretty Stable
Capital Expenditure Coverage Ratio10.029.543.611
Slightly volatile
Price Cash Flow Ratio17.0310.976715.5799
Slightly volatile
Enterprise Value Multiple12.9613.642425.8686
Slightly volatile
Debt Ratio0.550.44820.5077
Slightly volatile
Cash Flow To Debt Ratio0.0880.12450.1043
Slightly volatile
Price Sales Ratio10.025.03069.1751
Slightly volatile
Asset Turnover0.07650.12180.0943
Pretty Stable
Gross Profit Margin0.40.42310.8446
Slightly volatile
Price Fair Value1.531.17721.3969
Slightly volatile

Sabra Healthcare Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.5 B3.3 B2.1 B
Slightly volatile
Enterprise Value3.2 B5.7 B3.7 B
Slightly volatile

Sabra Fundamental Market Drivers

Forward Price Earnings8.7108
Cash And Short Term Investments46.7 M

Sabra Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Sabra Healthcare Financial Statements

Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-66.4 M-69.7 M
Total Revenue655.8 M404.9 M
Cost Of Revenue378.3 M397.2 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.07  0.11 
Capex To Revenue 0.07  0.06 
Revenue Per Share 2.84  2.47 
Ebit Per Revenue 0.33  0.47 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
How To Invest In Sabra
Details
Is Sabra Stock a good investment?
Details
What is Sabra Healthcare's Net Worth?
Details
Largest Diversified REITs Companies
View
Largest Equity Real Estate Investment Trusts (REITs) Companies
View
Check out the analysis of Sabra Healthcare Correlation against competitors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.111
Dividend Share
1.2
Earnings Share
0.41
Revenue Per Share
2.943
Quarterly Revenue Growth
0.107
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY